AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00906-07v1
52/2/786    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Galas, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Galas, M.
Antimicrobial Agents and Chemotherapy, February 2008, p. 786-789, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.00906-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Nationwide Study of the Prevalence, Characteristics, and Molecular Epidemiology of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae in France{triangledown}

Muriel Galas,1 Jean-Winoc Decousser,2,3* Nelly Breton,1 Thierry Godard,1 Pierre Yves Allouch,1 Patrick Pina,4 and the Collège de Bactériologie Virologie Hygiène (ColBVH) Study Group,{dagger}

Service d'Hygiène Hospitalière, Centre Hospitalier de Versailles, Le Chesnay, France,1 Service de Biologie et d'Hygiène, Centre Hospitalier de Dourdan, Dourdan, France,2 Service de Biologie, Centre Hospitalier de Rambouillet, Rambouillet, France,3 Service de Médecine B, Hôpital de Plaisir Grignon, Plaisir, France4

Received 11 July 2007/ Returned for modification 7 September 2007/ Accepted 6 November 2007

Among 10,872 isolates of Enterobacteriaceae from a nationwide study of 88 French hospitals in 2005, 169 (1.7%) expressed an extended-spectrum β-lactamase. The most prevalent species were Escherichia coli (48.5%), Enterobacter aerogenes (23.7%), and Klebsiella pneumoniae (14.8%). Molecular analysis underlined the polyclonal spread of CTX-M-expressing E. coli, primarily isolates of the CTX-M-1 subgroup.

* Corresponding author. Mailing address: Centre Hospitalier de Dourdan, 2 rue du Potelet, 91415 Dourdan cedex, France. Phone: 33 1 60 81 58 92. Fax: 33 1 60 81 58 97. E-mail: jean-winoc.decousser{at}wanadoo.fr

{triangledown} Published ahead of print on 19 November 2007.

{dagger} The ColBVH Study Group participants are listed in Acknowledgements.

Antimicrobial Agents and Chemotherapy, February 2008, p. 786-789, Vol. 52, No. 2
0066-4804/08/$08.00+0     doi:10.1128/AAC.00906-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.